Anne E de Papp Selected Research

Postmenopausal Osteoporosis

8/2014	Effects of odanacatib on the radius and tibia of postmenopausal women: improvements in bone geometry, microarchitecture, and estimated bone strength.
7/2006	Comparison of weekly treatment of postmenopausal osteoporosis with alendronate versus risedronate over two years.
9/2005	A randomized, placebo-controlled, 6-month study of once-weekly alendronate oral solution for postmenopausal osteoporosis.
1/2005	Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study.
12/2004	Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal osteoporosis.
7/2004	Once-weekly alendronate 70 mg and raloxifene 60 mg daily in the treatment of postmenopausal osteoporosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anne E de Papp Research Topics

Disease

6	Bone Resorption 01/2021 - 10/2002
6	Postmenopausal Osteoporosis 08/2014 - 07/2004
5	Osteoporosis 01/2019 - 10/2002
3	Metabolic Bone Diseases (Osteopenia) 12/2010 - 05/2007
1	Hypoalbuminemia 01/2002
1	Carcinoma (Carcinomatosis) 01/2002
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2002
1	Anemia 01/2002

Drug/Important Bio-Agent (IBA)

8	Alendronate (Alendronate Sodium)FDA LinkGeneric 12/2010 - 10/2002
4	collagen type I trimeric cross-linked peptideIBA 01/2021 - 10/2002
4	Alkaline PhosphataseIBA 01/2021 - 01/2002
4	Risedronic Acid (Actonel)FDA LinkGeneric 03/2010 - 12/2004
2	CollagenIBA 01/2021 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 05/2007
2	odanacatibIBA 08/2014 - 02/2013
2	Collagen Type I (Type I Collagen)IBA 02/2013 - 04/2009
1	Cathepsin KIBA 08/2014
1	CytokinesIBA 12/2012
1	ProcollagenIBA 04/2009
1	SolutionsIBA 09/2005
1	hydroxide ionIBA 06/2005
1	Vitamin D FDA LinkGeneric 06/2005
1	25-hydroxyvitamin DIBA 06/2005
1	NitrogenIBA 01/2005
1	Diphosphonates (Bisphosphonates)IBA 01/2005
1	Raloxifene Hydrochloride (Evista)FDA Link 07/2004
1	CreatinineIBA 10/2002
1	Thyroglobulin FDA Link 01/2002
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2002
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2002

Therapy/Procedure

4	Therapeutics 01/2019 - 12/2004
1	Hysterectomy 01/2002
1	Drug Therapy (Chemotherapy) 01/2002